Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer

Cédric Poyet, Peter J. Wild(University Hospital of Zurich)

Oncology Letters

September 9, 2015

10.3892/ol.2015.3691

Cited by 16

Related Papers

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer

|Oncotarget|2017|57

Alterations in <i>BAP1</i> Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

|Clinical Cancer Research|2021|43

Deep learning based on hematoxylin–eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma

|The Journal of Pathology|2022|27